Suppr超能文献

克隆无关性里希特综合征确实是新出现的弥漫性大 B 细胞淋巴瘤,其突变特征类似于克隆相关性里希特综合征。

Clonally unrelated Richter syndrome are truly de novo diffuse large B-cell lymphomas with a mutational profile reminiscent of clonally related Richter syndrome.

机构信息

Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.

Division of Pathology, Department of Health Sciences, Università del Piemonte Orientale, Novara, Italy.

出版信息

Br J Haematol. 2022 Sep;198(6):1016-1022. doi: 10.1111/bjh.18352. Epub 2022 Jul 13.

Abstract

Richter syndrome (RS) is mostly due to the direct transformation of the chronic lymphocytic leukaemia (CLL) clone, as documented by the same immunoglobulin heavy-chain variable region (IGHV) rearrangement in both CLL and RS cells. In rare cases characterized by a better outcome, the RS clone harbours a different IGHV rearrangement compared to the CLL phase. We investigated the CLL phase of clonally unrelated RS to test whether the RS clone was already identifiable prior to clinicopathologic transformation, albeit undetectable by conventional approaches. CLL cells of eight patients with unrelated RS were subjected to an ultra-deep next-generation sequencing (NGS) approach with a sensitivity of 10 . In 7/8 cases, the RS rearrangement was not identified in the CLL phase. In one case, the RS clone was identified at a very low frequency in the CLL phase, conceivably due to the concomitance of CLL sampling and RS diagnosis. Targeted resequencing revealed that clonally unrelated RS carries genetic lesions primarily affecting the TP53, MYC, ATM and NOTCH1 genes. Conversely, mutations frequently involved in de novo diffuse large B-cell lymphoma (DLBCL) without a history of CLL were absent. These results suggest that clonally unrelated RS is a truly de novo lymphoma with a mutational profile reminiscent, at least in part, of clonally related RS.

摘要

里希特综合征(RS)主要归因于慢性淋巴细胞白血病(CLL)克隆的直接转化,这在 CLL 和 RS 细胞中相同的免疫球蛋白重链可变区(IGHV)重排中得到证实。在一些预后较好的罕见病例中,与 CLL 期相比,RS 克隆具有不同的 IGHV 重排。我们研究了无关联 RS 的 CLL 期,以测试在临床病理转化之前是否已经可以识别 RS 克隆,尽管传统方法无法检测到。对 8 例无关联 RS 的 CLL 细胞进行了超高深度下一代测序(NGS)分析,其灵敏度为 10 。在 7/8 例中,未在 CLL 期识别到 RS 重排。在 1 例中,RS 克隆在 CLL 期以非常低的频率被识别到,这可能是由于 CLL 取样和 RS 诊断同时发生。靶向重测序显示,无关联的 RS 携带主要影响 TP53、MYC、ATM 和 NOTCH1 基因的遗传病变。相反,在没有 CLL 病史的新发弥漫性大 B 细胞淋巴瘤(DLBCL)中经常涉及的突变缺失。这些结果表明,无关联的 RS 是一种真正的新发淋巴瘤,其突变谱至少部分类似于有相关 RS。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22b8/9543999/853bdd4fd0ed/BJH-198-1016-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验